Biologic Options for Glenohumeral Arthritis

Area of Science:

• Orthopedic Surgery
• Regenerative Medicine

Background:

• Glenohumeral arthritis presents challenges in young patients, often requiring joint preservation strategies.
• Traditional treatments may not fully address pain and functional deficits.
• Biologic interventions offer novel approaches to managing shoulder arthritis.

Purpose of the Study:

• To review the current evidence for biologic treatments in young patients with glenohumeral arthritis.
• To evaluate the efficacy of hyaluronic acid injections, platelet-rich plasma, and allograft interposition arthroplasty.
• To assess the potential of these treatments in pain reduction, function improvement, and delaying arthroplasty.

Main Methods:

• Systematic review of existing literature.
• Analysis of studies focusing on hyaluronic acid injections.
• Evaluation of research on platelet-rich plasma (PRP) injections.
• Assessment of outcomes for allograft interposition arthroplasty.

Main Results:

• Hyaluronic acid injections show variable results in pain relief and function.
• Platelet-rich plasma (PRP) demonstrates potential for improving pain and function, though evidence is still evolving.
• Allograft interposition arthroplasty can provide pain relief and functional improvement, particularly in specific patient subgroups.

Conclusions:

• Biologic options offer promising alternatives for managing glenohumeral arthritis in young individuals.
• Further high-quality research is needed to establish optimal protocols and long-term outcomes.
• These treatments may help delay the need for definitive joint replacement surgery.